ID   DCR1C_HUMAN             Reviewed;         692 AA.
AC   Q96SD1; D3DRT6; Q1HCL2; Q5JSR4; Q5JSR5; Q5JSR7; Q5JSR8; Q5JSR9; Q5JSS0;
AC   Q5JSS7; Q6PK14; Q8N101; Q8N132; Q8TBW9; Q9BVW9; Q9HAM4;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   22-APR-2020, entry version 143.
DE   RecName: Full=Protein artemis;
DE            EC=3.1.-.-;
DE   AltName: Full=DNA cross-link repair 1C protein;
DE   AltName: Full=Protein A-SCID;
DE   AltName: Full=SNM1 homolog C;
DE            Short=hSNM1C;
DE   AltName: Full=SNM1-like protein;
GN   Name=DCLRE1C; Synonyms=ARTEMIS, ASCID, SCIDA, SNM1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   INVOLVEMENT IN RSSCID.
RX   PubMed=11336668; DOI=10.1016/S0092-8674(01)00309-9;
RA   Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M.,
RA   le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A.,
RA   de Villartay J.-P.;
RT   "Artemis, a novel DNA double-strand break repair/V(D)J recombination
RT   protein, is mutated in human severe combined immune deficiency.";
RL   Cell 105:177-186(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, AND INVOLVEMENT IN SCIDA.
RX   PubMed=12055248;
RA   Li L., Moshous D., Zhou Y., Wang J., Xie G., Salido E., Hu D.,
RA   de Villartay J.-P., Cowan M.J.;
RT   "A founder mutation in Artemis, an SNM1-like protein, causes SCID in
RT   Athabascan-speaking native Americans.";
RL   J. Immunol. 168:6323-6329(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT ARG-171.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-140; ARG-153; ARG-171;
RP   ARG-243; CYS-320 AND MET-329.
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 401-692 (ISOFORMS 1/2/3), AND VARIANT
RP   ARG-243.
RC   TISSUE=Cervix carcinoma, Lung carcinoma, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH PRKDC, PHOSPHORYLATION BY PRKDC, AND MUTAGENESIS
RP   OF ASP-165.
RX   PubMed=11955432; DOI=10.1016/S0092-8674(02)00671-2;
RA   Ma Y., Pannicke U., Schwarz K., Lieber M.R.;
RT   "Hairpin opening and overhang processing by an Artemis/DNA-dependent
RT   protein kinase complex in nonhomologous end joining and V(D)J
RT   recombination.";
RL   Cell 108:781-794(2002).
RN   [9]
RP   DNA REPAIR METALLO-BETA-LACTAMASE FAMILY.
RX   PubMed=12177301; DOI=10.1093/nar/gkf470;
RA   Callebaut I., Moshous D., Mornon J.-P., de Villartay J.-P.;
RT   "Metallo-beta-lactamase fold within nucleic acids processing enzymes: the
RT   beta-CASP family.";
RL   Nucleic Acids Res. 30:3592-3601(2002).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-17; HIS-33; HIS-35;
RP   ASP-37; HIS-38; HIS-115; ASP-136; ASP-165 AND HIS-319, AND PHOSPHORYLATION
RP   BY PRKDC.
RX   PubMed=15071507; DOI=10.1038/sj.emboj.7600206;
RA   Pannicke U., Ma Y., Hopfner K.-P., Niewolik D., Lieber M.R., Schwarz K.;
RT   "Functional and biochemical dissection of the structure-specific nuclease
RT   ARTEMIS.";
RL   EMBO J. 23:1987-1997(2004).
RN   [11]
RP   FUNCTION, MUTAGENESIS OF SER-516; SER-534; SER-538; SER-548; SER-553;
RP   SER-561 AND SER-562, PHOSPHORYLATION BY ATM, AND PHOSPHORYLATION AT
RP   SER-645.
RX   PubMed=15468306; DOI=10.1002/eji.200425455;
RA   Poinsignon C., de Chasseval R., Soubeyrand S., Moshous D., Fischer A.,
RA   Hache R.J.G., de Villartay J.-P.;
RT   "Phosphorylation of Artemis following irradiation-induced DNA damage.";
RL   Eur. J. Immunol. 34:3146-3155(2004).
RN   [12]
RP   FUNCTION, INTERACTION WITH PRKDC, AND MUTAGENESIS OF ASP-17; HIS-33;
RP   HIS-35; ASP-37; HIS-38; HIS-115; ASP-136; ASP-165 AND HIS-319.
RX   PubMed=14744996; DOI=10.1084/jem.20031142;
RA   Poinsignon C., Moshous D., Callebaut I., de Chasseval R., Villey I.,
RA   de Villartay J.-P.;
RT   "The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the
RT   catalytic core for V(D)J recombination.";
RL   J. Exp. Med. 199:315-321(2004).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH PRKDC.
RX   PubMed=15574326; DOI=10.1016/j.molcel.2004.11.017;
RA   Ma Y., Lu H., Tippin B., Goodman M.F., Shimazaki N., Koiwai O.,
RA   Hsieh C.-L., Schwarz K., Lieber M.R.;
RT   "A biochemically defined system for mammalian nonhomologous DNA end
RT   joining.";
RL   Mol. Cell 16:701-713(2004).
RN   [14]
RP   FUNCTION, INTERACTION WITH TP53BP1, MUTAGENESIS OF ASP-37, AND
RP   PHOSPHORYLATION BY ATM.
RX   PubMed=15574327; DOI=10.1016/j.molcel.2004.10.029;
RA   Riballo E., Kuehne M., Rief N., Doherty A., Smith G.C.M., Recio M.-J.,
RA   Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P.,
RA   Gennery A., Jeggo P.A., Loebrich M.;
RT   "A pathway of double-strand break rejoining dependent upon ATM, Artemis,
RT   and proteins locating to gamma-H2AX foci.";
RL   Mol. Cell 16:715-724(2004).
RN   [15]
RP   FUNCTION, INTERACTION WITH ATM; BRCA1; THE MRN COMPLEX AND PRKDC, AND
RP   PHOSPHORYLATION BY ATM; ATR AND PRKDC.
RX   PubMed=15456891; DOI=10.1128/MCB.24.20.9207-9220.2004;
RA   Zhang X., Succi J., Feng Z., Prithivirajsingh S., Story M.D.,
RA   Legerski R.J.;
RT   "Artemis is a phosphorylation target of ATM and ATR and is involved in the
RT   G2/M DNA damage checkpoint response.";
RL   Mol. Cell. Biol. 24:9207-9220(2004).
RN   [16]
RP   INTERACTION WITH THE MRN COMPLEX, PHOSPHORYLATION BY ATM, AND
RP   PHOSPHORYLATION AT SER-645.
RX   PubMed=15723659; DOI=10.1111/j.1349-7006.2005.00019.x;
RA   Chen L., Morio T., Minegishi Y., Nakada S., Nagasawa M., Komatsu K.,
RA   Chessa L., Villa A., Lecis D., Delia D., Mizutani S.;
RT   "Ataxia-telangiectasia-mutated dependent phosphorylation of Artemis in
RT   response to DNA damage.";
RL   Cancer Sci. 96:134-141(2005).
RN   [17]
RP   FUNCTION, PHOSPHORYLATION BY PRKDC, AND PHOSPHORYLATION IN RESPONSE TO DNA
RP   DAMAGE.
RX   PubMed=15811628; DOI=10.1016/j.dnarep.2005.02.001;
RA   Wang J., Pluth J.M., Cooper P.K., Cowan M.J., Chen D.J., Yannone S.M.;
RT   "Artemis deficiency confers a DNA double-strand break repair defect and
RT   Artemis phosphorylation status is altered by DNA damage and cell cycle
RT   progression.";
RL   DNA Repair 4:556-570(2005).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH PRKDC.
RX   PubMed=15936993; DOI=10.1016/j.dnarep.2005.04.013;
RA   Ma Y., Schwarz K., Lieber M.R.;
RT   "The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps.";
RL   DNA Repair 4:845-851(2005).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   VARIANTS RSSCID VAL-118 AND GLU-135.
RX   PubMed=12406895; DOI=10.1182/blood-2002-01-0187;
RA   Noordzij J.G., Verkaik N.S., van der Burg M., van Veelen L.R.,
RA   de Bruin-Versteeg S., Wiegant W., Vossen J.M.J.J., Weemaes C.M.R.,
RA   de Groot R., Zdzienicka M.Z., van Gent D.C., van Dongen J.J.M.;
RT   "Radiosensitive SCID patients with Artemis gene mutations show a complete
RT   B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone
RT   marrow.";
RL   Blood 101:1446-1452(2003).
RN   [22]
RP   INVOLVEMENT IN RSSCID.
RX   PubMed=12921762; DOI=10.1016/S1521-6616(03)00095-0;
RA   Kobayashi N., Agematsu K., Nagumo H., Yasui K., Katsuyama Y., Yoshizawa K.,
RA   Ota M., Yachie A., Komiyama A.;
RT   "Expansion of clonotype-restricted HLA-identical maternal CD4+ T cells in a
RT   patient with severe combined immunodeficiency and a homozygous mutation in
RT   the Artemis gene.";
RL   Clin. Immunol. 108:159-166(2003).
RN   [23]
RP   INVOLVEMENT IN RSSCID.
RX   PubMed=12592555; DOI=10.1007/s00439-002-0897-x;
RA   Kobayashi N., Agematsu K., Sugita K., Sako M., Nonoyama S., Yachie A.,
RA   Kumaki S., Tsuchiya S., Ochs H.D., Sugita K., Fukushima Y., Komiyama A.;
RT   "Novel Artemis gene mutations of radiosensitive severe combined
RT   immunodeficiency in Japanese families.";
RL   Hum. Genet. 112:348-352(2003).
RN   [24]
RP   VARIANT OMENN SYNDROME ASP-35.
RX   PubMed=15731174; DOI=10.1182/blood-2004-12-4861;
RA   Ege M., Ma Y., Manfras B., Kalwak K., Lu H., Lieber M.R., Schwarz K.,
RA   Pannicke U.;
RT   "Omenn syndrome due to ARTEMIS mutations.";
RL   Blood 105:4179-4186(2005).
RN   [25]
RP   INVOLVEMENT IN RSSCID.
RX   PubMed=12569164;
RA   Moshous D., Pannetier C., de Chasseval R., le Deist F., Cavazzana-Calvo M.,
RA   Romana S., Macintyre E., Canioni D., Brousse N., Fischer A.,
RA   Casanova J.-L., de Villartay J.-P.;
RT   "Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma
RT   in patients with hypomorphic mutations in Artemis.";
RL   J. Clin. Invest. 111:381-387(2003).
CC   -!- FUNCTION: Required for V(D)J recombination, the process by which exons
CC       encoding the antigen-binding domains of immunoglobulins and T-cell
CC       receptor proteins are assembled from individual V, (D), and J gene
CC       segments. V(D)J recombination is initiated by the lymphoid specific RAG
CC       endonuclease complex, which generates site specific DNA double strand
CC       breaks (DSBs). These DSBs present two types of DNA end structures:
CC       hairpin sealed coding ends and phosphorylated blunt signal ends. These
CC       ends are independently repaired by the non homologous end joining
CC       (NHEJ) pathway to form coding and signal joints respectively. This
CC       protein exhibits single-strand specific 5'-3' exonuclease activity in
CC       isolation and acquires endonucleolytic activity on 5' and 3' hairpins
CC       and overhangs when in a complex with PRKDC. The latter activity is
CC       required specifically for the resolution of closed hairpins prior to
CC       the formation of the coding joint. May also be required for the repair
CC       of complex DSBs induced by ionizing radiation, which require
CC       substantial end-processing prior to religation by NHEJ.
CC       {ECO:0000269|PubMed:11336668, ECO:0000269|PubMed:11955432,
CC       ECO:0000269|PubMed:12055248, ECO:0000269|PubMed:14744996,
CC       ECO:0000269|PubMed:15071507, ECO:0000269|PubMed:15456891,
CC       ECO:0000269|PubMed:15468306, ECO:0000269|PubMed:15574326,
CC       ECO:0000269|PubMed:15574327, ECO:0000269|PubMed:15811628,
CC       ECO:0000269|PubMed:15936993}.
CC   -!- SUBUNIT: Interacts with ATM, BRCA1, PRKDC and TP53BP1. Also exhibits
CC       ATM- and phosphorylation-dependent interaction with the MRN complex,
CC       composed of MRE11, RAD50, and NBN. {ECO:0000269|PubMed:11955432,
CC       ECO:0000269|PubMed:14744996, ECO:0000269|PubMed:15456891,
CC       ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:15574327,
CC       ECO:0000269|PubMed:15723659, ECO:0000269|PubMed:15936993}.
CC   -!- INTERACTION:
CC       Q96SD1; P49917: LIG4; NbExp=16; IntAct=EBI-11694104, EBI-847896;
CC       Q96SD1; P78527: PRKDC; NbExp=4; IntAct=EBI-11694104, EBI-352053;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12055248,
CC       ECO:0000269|PubMed:15071507}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96SD1-1; Sequence=Displayed;
CC       Name=2; Synonyms=SCIDA;
CC         IsoId=Q96SD1-2; Sequence=VSP_014888;
CC       Name=3;
CC         IsoId=Q96SD1-3; Sequence=VSP_014889, VSP_014890;
CC       Name=4;
CC         IsoId=Q96SD1-4; Sequence=VSP_014891, VSP_014892;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in the
CC       kidney, lung, pancreas and placenta (at the mRNA level). Expression is
CC       not increased in thymus or bone marrow, sites of V(D)J recombination.
CC       {ECO:0000269|PubMed:11336668}.
CC   -!- PTM: Phosphorylation on undefined residues by PRKDC may stimulate
CC       endonucleolytic activity on 5' and 3' hairpins and overhangs. PRKDC
CC       must remain present, even after phosphorylation, for efficient hairpin
CC       opening. Also phosphorylated by ATM in response to ionizing radiation
CC       (IR) and by ATR in response to ultraviolet (UV) radiation.
CC       {ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:15071507,
CC       ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15468306,
CC       ECO:0000269|PubMed:15574327, ECO:0000269|PubMed:15723659,
CC       ECO:0000269|PubMed:15811628}.
CC   -!- DISEASE: Severe combined immunodeficiency autosomal recessive T-cell-
CC       negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing
CC       radiation (RSSCID) [MIM:602450]: A form of severe combined
CC       immunodeficiency, a genetically and clinically heterogeneous group of
CC       rare congenital disorders characterized by impairment of both humoral
CC       and cell-mediated immunity, leukopenia, and low or absent antibody
CC       levels. Patients present in infancy with recurrent, persistent
CC       infections by opportunistic organisms. The common characteristic of all
CC       types of SCID is absence of T-cell-mediated cellular immunity due to a
CC       defect in T-cell development. Individuals affected by RS-SCID show
CC       defects in the DNA repair machinery necessary for coding joint
CC       formation and the completion of V(D)J recombination. A subset of cells
CC       from such patients show increased radiosensitivity.
CC       {ECO:0000269|PubMed:11336668, ECO:0000269|PubMed:12406895,
CC       ECO:0000269|PubMed:12569164, ECO:0000269|PubMed:12592555,
CC       ECO:0000269|PubMed:12921762}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Severe combined immunodeficiency Athabaskan type (SCIDA)
CC       [MIM:602450]: A variety of SCID with sensitivity to ionizing radiation.
CC       A founder mutation has been detected in Athabascan-speaking native
CC       Americans, being inherited as an autosomal recessive trait. Affected
CC       individuals exhibit clinical symptoms and defects in DNA repair
CC       comparable to those seen in RS-SCID. {ECO:0000269|PubMed:12055248}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Omenn syndrome (OS) [MIM:603554]: Severe immunodeficiency
CC       characterized by the presence of activated, anergic, oligoclonal T-
CC       cells, hypereosinophilia, and high IgE levels.
CC       {ECO:0000269|PubMed:15731174}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DNA repair metallo-beta-lactamase (DRMBL)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=DCLRE1Cbase; Note=DCLRE1C mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/DCLRE1Cbase/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/dclre1c/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ296101; CAC37570.1; -; mRNA.
DR   EMBL; AF395747; AAM53255.1; -; mRNA.
DR   EMBL; AF395748; AAM53256.1; -; mRNA.
DR   EMBL; AF395749; AAM53257.1; -; mRNA.
DR   EMBL; AF395750; AAM53258.1; -; mRNA.
DR   EMBL; AF395751; AAM53259.1; -; mRNA.
DR   EMBL; AF395752; AAM53260.1; -; mRNA.
DR   EMBL; AK021422; BAB13820.1; -; mRNA.
DR   EMBL; DQ504427; ABF47101.1; -; Genomic_DNA.
DR   EMBL; AC069544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86248.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86250.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86251.1; -; Genomic_DNA.
DR   EMBL; BC000863; AAH00863.1; -; mRNA.
DR   EMBL; BC009185; AAH09185.1; -; mRNA.
DR   EMBL; BC022254; AAH22254.1; -; mRNA.
DR   CCDS; CCDS31149.1; -. [Q96SD1-1]
DR   CCDS; CCDS31150.1; -. [Q96SD1-2]
DR   CCDS; CCDS7105.1; -. [Q96SD1-3]
DR   RefSeq; NP_001029027.1; NM_001033855.2. [Q96SD1-1]
DR   RefSeq; NP_001029029.1; NM_001033857.2. [Q96SD1-2]
DR   RefSeq; NP_001029030.1; NM_001033858.2. [Q96SD1-2]
DR   RefSeq; NP_001276005.1; NM_001289076.1. [Q96SD1-3]
DR   RefSeq; NP_001276006.1; NM_001289077.1. [Q96SD1-2]
DR   RefSeq; NP_001276007.1; NM_001289078.1. [Q96SD1-3]
DR   RefSeq; NP_001276008.1; NM_001289079.1. [Q96SD1-2]
DR   RefSeq; NP_071932.2; NM_022487.3. [Q96SD1-3]
DR   RefSeq; XP_006717554.1; XM_006717491.3. [Q96SD1-3]
DR   RefSeq; XP_011517918.1; XM_011519616.1. [Q96SD1-3]
DR   RefSeq; XP_011517919.1; XM_011519617.1. [Q96SD1-3]
DR   RefSeq; XP_011517921.1; XM_011519619.1. [Q96SD1-2]
DR   RefSeq; XP_016872046.1; XM_017016557.1. [Q96SD1-3]
DR   RefSeq; XP_016872047.1; XM_017016558.1. [Q96SD1-2]
DR   PDB; 3W1B; X-ray; 2.40 A; B=485-495.
DR   PDB; 3W1G; X-ray; 2.55 A; B=485-495.
DR   PDB; 4HTP; X-ray; 2.25 A; C/E=485-495.
DR   PDBsum; 3W1B; -.
DR   PDBsum; 3W1G; -.
DR   PDBsum; 4HTP; -.
DR   SMR; Q96SD1; -.
DR   BioGrid; 122170; 36.
DR   CORUM; Q96SD1; -.
DR   IntAct; Q96SD1; 21.
DR   STRING; 9606.ENSP00000367527; -.
DR   BindingDB; Q96SD1; -.
DR   iPTMnet; Q96SD1; -.
DR   PhosphoSitePlus; Q96SD1; -.
DR   BioMuta; DCLRE1C; -.
DR   DMDM; 71153325; -.
DR   jPOST; Q96SD1; -.
DR   MassIVE; Q96SD1; -.
DR   PaxDb; Q96SD1; -.
DR   PeptideAtlas; Q96SD1; -.
DR   PRIDE; Q96SD1; -.
DR   ProteomicsDB; 78103; -. [Q96SD1-1]
DR   ProteomicsDB; 78104; -. [Q96SD1-2]
DR   ProteomicsDB; 78105; -. [Q96SD1-3]
DR   ProteomicsDB; 78106; -. [Q96SD1-4]
DR   Antibodypedia; 24989; 339 antibodies.
DR   Ensembl; ENST00000357717; ENSP00000350349; ENSG00000152457. [Q96SD1-3]
DR   Ensembl; ENST00000378246; ENSP00000367492; ENSG00000152457. [Q96SD1-3]
DR   Ensembl; ENST00000378249; ENSP00000367496; ENSG00000152457. [Q96SD1-3]
DR   Ensembl; ENST00000378254; ENSP00000367502; ENSG00000152457. [Q96SD1-2]
DR   Ensembl; ENST00000378255; ENSP00000367503; ENSG00000152457. [Q96SD1-2]
DR   Ensembl; ENST00000378258; ENSP00000367506; ENSG00000152457. [Q96SD1-2]
DR   Ensembl; ENST00000378278; ENSP00000367527; ENSG00000152457. [Q96SD1-1]
DR   Ensembl; ENST00000378289; ENSP00000367538; ENSG00000152457. [Q96SD1-4]
DR   Ensembl; ENST00000396817; ENSP00000380030; ENSG00000152457. [Q96SD1-2]
DR   GeneID; 64421; -.
DR   KEGG; hsa:64421; -.
DR   UCSC; uc001inl.5; human. [Q96SD1-1]
DR   CTD; 64421; -.
DR   DisGeNET; 64421; -.
DR   GeneCards; DCLRE1C; -.
DR   HGNC; HGNC:17642; DCLRE1C.
DR   HPA; ENSG00000152457; Low tissue specificity.
DR   MalaCards; DCLRE1C; -.
DR   MIM; 602450; phenotype.
DR   MIM; 603554; phenotype.
DR   MIM; 605988; gene.
DR   neXtProt; NX_Q96SD1; -.
DR   OpenTargets; ENSG00000152457; -.
DR   Orphanet; 39041; Omenn syndrome.
DR   Orphanet; 275; Severe combined immunodeficiency due to DCLRE1C deficiency.
DR   PharmGKB; PA27176; -.
DR   eggNOG; KOG1361; Eukaryota.
DR   eggNOG; COG1236; LUCA.
DR   GeneTree; ENSGT00940000157779; -.
DR   HOGENOM; CLU_005260_1_1_1; -.
DR   InParanoid; Q96SD1; -.
DR   OMA; CYSTHAS; -.
DR   OrthoDB; 1441774at2759; -.
DR   PhylomeDB; Q96SD1; -.
DR   TreeFam; TF329572; -.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   SIGNOR; Q96SD1; -.
DR   ChiTaRS; DCLRE1C; human.
DR   GenomeRNAi; 64421; -.
DR   Pharos; Q96SD1; Tbio.
DR   PRO; PR:Q96SD1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q96SD1; protein.
DR   Bgee; ENSG00000152457; Expressed in buccal mucosa cell and 234 other tissues.
DR   ExpressionAtlas; Q96SD1; baseline and differential.
DR   Genevisible; Q96SD1; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0070419; C:nonhomologous end joining complex; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0035312; F:5'-3' exodeoxyribonuclease activity; IBA:GO_Central.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IDA:MGI.
DR   GO; GO:0003684; F:damaged DNA binding; IBA:GO_Central.
DR   GO; GO:0004519; F:endonuclease activity; TAS:Reactome.
DR   GO; GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; IDA:MGI.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IBA:GO_Central.
DR   GO; GO:0036297; P:interstrand cross-link repair; IBA:GO_Central.
DR   GO; GO:0031848; P:protection from non-homologous end joining at telomere; IBA:GO_Central.
DR   GO; GO:0010212; P:response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0033151; P:V(D)J recombination; IEA:Ensembl.
DR   DisProt; DP01162; -.
DR   Gene3D; 3.60.15.10; -; 1.
DR   InterPro; IPR011084; DRMBL.
DR   InterPro; IPR001279; Metallo-B-lactamas.
DR   InterPro; IPR036866; RibonucZ/Hydroxyglut_hydro.
DR   Pfam; PF07522; DRMBL; 1.
DR   Pfam; PF12706; Lactamase_B_2; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Disease mutation;
KW   DNA damage; DNA recombination; DNA repair; Endonuclease; Exonuclease;
KW   Hydrolase; Immunity; Magnesium; Nuclease; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; SCID.
FT   CHAIN           1..692
FT                   /note="Protein artemis"
FT                   /id="PRO_0000209122"
FT   MOD_RES         380
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K4J0"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K4J0"
FT   MOD_RES         645
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000269|PubMed:15468306,
FT                   ECO:0000269|PubMed:15723659"
FT   VAR_SEQ         1..120
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12055248"
FT                   /id="VSP_014888"
FT   VAR_SEQ         1..115
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12055248,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014889"
FT   VAR_SEQ         116..121
FT                   /note="CPGSVM -> MKHQER (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12055248,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014890"
FT   VAR_SEQ         386..434
FT                   /note="EEEDDYLFDDPLPIPLRHKVPYPETFHPEVFSMTAVSEKQPEKLRQTPG ->
FT                   GSHSVTQARMRWCHHDSLYPLTPGIKRSSCLSLLTSWITGAYRHAQLMI (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014891"
FT   VAR_SEQ         435..692
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014892"
FT   VARIANT         35
FT                   /note="H -> D (in Omenn syndrome; dbSNP:rs121908159)"
FT                   /evidence="ECO:0000269|PubMed:15731174"
FT                   /id="VAR_023077"
FT   VARIANT         118
FT                   /note="G -> V (in RSSCID)"
FT                   /evidence="ECO:0000269|PubMed:12406895"
FT                   /id="VAR_023078"
FT   VARIANT         135
FT                   /note="G -> E (in RSSCID)"
FT                   /evidence="ECO:0000269|PubMed:12406895"
FT                   /id="VAR_023079"
FT   VARIANT         140
FT                   /note="A -> V (in dbSNP:rs41297016)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_060689"
FT   VARIANT         153
FT                   /note="G -> R (in dbSNP:rs41297018)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_060690"
FT   VARIANT         171
FT                   /note="P -> R (in dbSNP:rs35441642)"
FT                   /evidence="ECO:0000269|PubMed:14702039, ECO:0000269|Ref.4"
FT                   /id="VAR_048892"
FT   VARIANT         243
FT                   /note="H -> R (in dbSNP:rs12768894)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4"
FT                   /id="VAR_048893"
FT   VARIANT         320
FT                   /note="S -> C (in dbSNP:rs41298896)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_048894"
FT   VARIANT         329
FT                   /note="L -> M (in dbSNP:rs41299658)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_060691"
FT   MUTAGEN         17
FT                   /note="D->N,A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         33
FT                   /note="H->A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         35
FT                   /note="H->A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         37
FT                   /note="D->N,A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507, ECO:0000269|PubMed:15574327"
FT   MUTAGEN         38
FT                   /note="H->A: Reduces PRKDC-dependent endonuclease activity,
FT                   although V(D)J recombination is largely normal"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         115
FT                   /note="H->A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         136
FT                   /note="D->N,A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         165
FT                   /note="D->N,A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:11955432,
FT                   ECO:0000269|PubMed:14744996, ECO:0000269|PubMed:15071507"
FT   MUTAGEN         319
FT                   /note="H->A: Abolishes PRKDC-dependent endonuclease
FT                   activity and V(D)J recombination"
FT                   /evidence="ECO:0000269|PubMed:14744996,
FT                   ECO:0000269|PubMed:15071507"
FT   MUTAGEN         516
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-534; A-538; A-548; A-553; A-561 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         534
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-538; A-548; A-553; A-561 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         538
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-534; A-548; A-553; A-561 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         548
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-534; A-538; A-553; A-561 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         553
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-534; A-538; A-548; A-561 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         561
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-534; A-538; A-548; A-553 and A-
FT                   562"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   MUTAGEN         562
FT                   /note="S->A: Reduced IR induced phosphorylation; when
FT                   associated with A-516; A-534; A-538; A-548; A-553 and A-
FT                   561"
FT                   /evidence="ECO:0000269|PubMed:15468306"
FT   CONFLICT        560
FT                   /note="L -> V (in Ref. 1; CAC37570 and 2; AAM53255/
FT                   AAM53256/AAM53257/AAM53258/AAM53259/AAM53260)"
FT                   /evidence="ECO:0000305"
FT   HELIX           489..491
FT                   /evidence="ECO:0000244|PDB:4HTP"
SQ   SEQUENCE   692 AA;  78436 MW;  24B857F5B473637B CRC64;
     MSSFEGQMAE YPTISIDRFD RENLRARAYF LSHCHKDHMK GLRAPTLKRR LECSLKVYLY
     CSPVTKELLL TSPKYRFWKK RIISIEIETP TQISLVDEAS GEKEEIVVTL LPAGHCPGSV
     MFLFQGNNGT VLYTGDFRLA QGEAARMELL HSGGRVKDIQ SVYLDTTFCD PRFYQIPSRE
     ECLSGVLELV RSWITRSPYH VVWLNCKAAY GYEYLFTNLS EELGVQVHVN KLDMFRNMPE
     ILHHLTTDRN TQIHACRHPK AEEYFQWSKL PCGITSRNRI PLHIISIKPS TMWFGERSRK
     TNVIVRTGES SYRACFSFHS SYSEIKDFLS YLCPVNAYPN VIPVGTTMDK VVEILKPLCR
     SSQSTEPKYK PLGKLKRART VHRDSEEEDD YLFDDPLPIP LRHKVPYPET FHPEVFSMTA
     VSEKQPEKLR QTPGCCRAEC MQSSRFTNFV DCEESNSESE EEVGIPASLQ GDLGSVLHLQ
     KADGDVPQWE VFFKRNDEIT DESLENFPSS TVAGGSQSPK LFSDSDGEST HISSQNSSQS
     THITEQGSQG WDSQSDTVLL SSQERNSGDI TSLDKADYRP TIKENIPASL MEQNVICPKD
     TYSDLKSRDK DVTIVPSTGE PTTLSSETHI PEEKSLLNLS TNADSQSSSD FEVPSTPEAE
     LPKREHLQYL YEKLATGESI AVKKRKCSLL DT
//
